Item 2. Properties
Item 2. Properties
We conduct our research, development, manufacturing, and administrative activities at our owned and leased facilities. A summary of our significant owned and leased properties is provided below.
Location
Approximate Square Feet
Use
Leased/Owned
Tarrytown, New York
1,500,000 Corporate headquarters, laboratory, and office space
Leased (a)
Rensselaer, New York 1,600,000 Manufacturing, warehouse, laboratory, fill/finish (b) , and office space
Owned
Limerick, Ireland
850,000 Manufacturing, warehouse, laboratory, and office space
Owned
(a) Refer to Part II, Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources - Tarrytown, New York Corporate Headquarters Lease " for further details.
(b) Our fill/finish facility in Rensselaer, New York is currently undergoing process validation as required by regulatory authorities.
In addition to the properties summarized in the table above, we own an approximate 100-acre parcel of land adjacent to our Tarrytown, New York location, which we are in the process of developing, primarily to expand our research, preclinical manufacturing, and support facilities to accommodate our growth. In September 2024, we also acquired an approximate 1,000,000 square foot facility in Saratoga Springs, New York.
Item 3. Legal Proceedings
The information called for by this item is incorporated herein by reference to the information set forth in Note 16 to our Consolidated Financial Statements included in this report.
Item 4. Mine Safety Disclosures
Not applicable.
68
Table of Contents
PART II
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.